EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design of a Randomized Sham-Controlled Trial: Strengthening Positive Treatment Expectations Using a Communication Model for Maximized Antiemetic Effects of Acupuncture and Antiemetics During Emetogenic Neo-/Adjuvant Chemotherapy

Widgren Ylva iD, Fransson Per, Englund Erling, Efverman Anna iD

Integrative Cancer Therapies · 2025

DOI: 10.1177/15347354251361464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrative Cancer Therapies, 2025. Verfasst von Widgren Ylva und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Gävle, Sweden. Hauptthemen laut MEDLINE: Acupuncture Therapy, Antiemetics, Antineoplastic Agents, Nausea. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy-induced nausea and vomiting is a common problem in patients undergoing chemotherapy, influencing quality of life (QoL) and daily activities. This study will investigate whether therapists’ positive communication may strengthen positive treatment expectations and induce antiemetic effects during antiemetic treatment using standard care, sham acupuncture, or verum acupuncture, compared to neutral communication. It will also investigate whether a variety of patient, therapist and treatment components modify the treatment outcomes.

Methods

This is a trial protocol for a randomized, sham-controlled, patient- and evaluator-blinded clinical trial. Patients (n = 198 patients according to a sample size calculation) with breast, colorectal, or bladder cancer undergoing neo-/adjuvant moderately to highly emetogenic chemotherapy are being randomized in 2 × 3 factorial design to the following conditions: 1. neutral or 2. positive communication style regarding expected treatment effects, during the antiemetic treatment types: A) standard care only (including antiemetics, no acupuncture), or, in addition to standard care, B) sham acupuncture with telescopic non-penetrating needles, or C) verum, penetrating acupuncture. The 2 communication styles 1 and 2 are carried out during the antiemetic treatments given by an intervention therapist immediately pre and post (20 minutes × 2) an intravenous chemotherapy session. Data are being collected at baseline on the day before the chemotherapy session, daily for 10 days, at a 10-day follow-up, and at a follow-up after completing the entire chemotherapy period, lasting about 6 months. Primary outcome is mean score Visual Analog Scale nausea grading for the first 5 days of the chemotherapy session period. Secondary outcomes are for example, vomiting, treatment expectations, QoL, daily and physical activity, and physiological measures. Treatment effect modifiers will be analyzed, for example, blinding success, treatment expectations, and previous nausea experiences.

Conclusions

This trial will expand integrative cancer care’s understanding of the effects of communication for strengthening treatment expectations and thus alleviating chemotherapy-induced nausea and vomiting. If proven effective, the communication model of strengthening positive treatment expectations in patients with risk for nausea and vomiting can be implemented in routine clinical care as part of side-effect management for patients with cancer.

Trial registration

US National Institutes of Health, https://clinicaltrials.gov/study/NCT03232541?term=NCT03232541&rank=1 ), # NCT03232541.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acupuncture TherapyAntiemeticsAntineoplastic AgentsNauseaVomitingAdultFemaleHumansMaleChemotherapy, AdjuvantCommunicationNeoadjuvant TherapyNeoplasmsQuality of LifeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

communicationcontextemesisexpectancynauseaplacebovomiting

Substanzen

AntiemeticsAntineoplastic Agents

Autor:innen und Institutionen

  • University of Gävle, Sweden.
  • Sundsvall Hospital, Sweden.
  • Umeå University, Sweden.
  • Research and Development, Region of Västernorrland, Sweden.

ORCID-Profile: Widgren Ylva, Efverman Anna

Zitieren

APA

Ylva, W., Per, F., Erling, E., & Anna, E. (2025). Design of a Randomized Sham-Controlled Trial: Strengthening Positive Treatment Expectations Using a Communication Model for Maximized Antiemetic Effects of Acupuncture and Antiemetics During Emetogenic Neo-/Adjuvant Chemotherapy. Integrative Cancer Therapies. https://doi.org/10.1177/15347354251361464

Vancouver

Ylva W, Per F, Erling E, Anna E. Design of a Randomized Sham-Controlled Trial: Strengthening Positive Treatment Expectations Using a Communication Model for Maximized Antiemetic Effects of Acupuncture and Antiemetics During Emetogenic Neo-/Adjuvant Chemotherapy. Integrative Cancer Therapies. 2025. doi:10.1177/15347354251361464

BibTeX
@article{Ylva2025,
  author = {Ylva, Widgren and Per, Fransson and Erling, Englund and Anna, Efverman},
  title = {Design of a Randomized Sham-Controlled Trial: Strengthening Positive Treatment Expectations Using a Communication Model for Maximized Antiemetic Effects of Acupuncture and Antiemetics During Emetogenic Neo-/Adjuvant Chemotherapy},
  journal = {Integrative Cancer Therapies},
  year = {2025},
  doi = {10.1177/15347354251361464}
}
Kostenlos starten →